{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:34Z","timestamp":1785801634616,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-02448-3","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T03:50:06Z","timestamp":1717041006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells"],"prefix":"10.1007","volume":"47","author":[{"given":"Zhengyou","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanjing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"2448_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","volume":"21","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S (2016) A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med 21:55\u201370","journal-title":"Environ Health Prev Med"},{"key":"2448_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS (2016) Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke 18:2\u201311","journal-title":"J Stroke"},{"key":"2448_CR3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ene.12702","volume":"22","author":"G Acker","year":"2015","unstructured":"Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P (2015) Distinct clinical and radiographic characteristics of moyamoya disease amongst European caucasians. Eur J Neurol 22:1012\u20131017","journal-title":"Eur J Neurol"},{"key":"2448_CR4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056\u20131066","journal-title":"Lancet Neurol"},{"issue":"3","key":"2448_CR5","first-page":"57","volume":"25","author":"Y Xueli","year":"2018","unstructured":"Xueli Y, Xingli Y (2018) Differences in the expression levels of MMP and VEGF in adult ischemic and outgoing MMD patients and their relationship with the degree of disease [J]. Stroke Neurol Disorders 25(3):57\u201360","journal-title":"Stroke Neurol Disorders"},{"key":"2448_CR6","doi-asserted-by":"crossref","first-page":"E320","DOI":"10.1227\/NEU.0b013e31827bc1c1","volume":"72","author":"AS Achrol","year":"2013","unstructured":"Achrol AS, Khan N, Steinberg GK (2013) The genetics of moyamoya disease: recent insights into the pathogenesis of the disease. Neurosurgery 72:E320\u2013E321","journal-title":"Neurosurgery"},{"key":"2448_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhg.2010.103","volume":"55","author":"C Roder","year":"2010","unstructured":"Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B (2010) Genetics of Moyamoya disease. J Hum Genet 55:711\u2013716","journal-title":"J Hum Genet"},{"key":"2448_CR8","first-page":"105","volume":"40","author":"A Koizumi","year":"2012","unstructured":"Koizumi A, Kobayashi H, Hitomi T (2012) Genes associated with moyamoya syndrome and disease[J]. No Shinkei Geka 40:105\u2013118","journal-title":"No Shinkei Geka"},{"key":"2448_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N et al (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56:34\u201340","journal-title":"J Hum Genet"},{"key":"2448_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.23736\/S0390-5616.16.03900-X","volume":"64","author":"A Raso","year":"2020","unstructured":"Raso A, Biassoni R, Mascelli S, Nozza P, Ugolotti E, Di Marco E, De Marco P, Merello E, Cama A, Pavanello M et al (2020) Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. J Neurosurg Sci 64:165\u2013172","journal-title":"J Neurosurg Sci"},{"key":"2448_CR11","doi-asserted-by":"crossref","unstructured":"Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, Mundlos S, Vajkoczy P (2021) The genetic basis of Moyamoya Disease. Transl Stroke Res 1\u201321","DOI":"10.1007\/s12975-021-00940-2"},{"key":"2448_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12199-012-0299-1","volume":"18","author":"H Akio Koizumi","year":"2013","unstructured":"Akio Koizumi H, Kobayashi W, Liu et al (2013) P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure[J]. Environ Health Prev Med 18:121\u2013129","journal-title":"Environ Health Prev Med"},{"key":"2448_CR13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chest.2017.09.023","volume":"153","author":"SA Chang","year":"2018","unstructured":"Chang SA et al (2018) Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of co-occurrence of moyamoya disease. Chest 153:404\u2013413","journal-title":"Chest"},{"key":"2448_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","volume":"41","author":"A Bersano","year":"2016","unstructured":"Bersano A, Guey S, Bedini G, Nava S, Herv\u00e9 D, Vajkoczy P, Tatlisumak T, Sareela M, Van Der Zwan A, Klijn CJ et al (2016) Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc Dis 41:105\u2013118","journal-title":"Cerebrovasc Dis"},{"key":"2448_CR15","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.3390\/ijms21165763","volume":"21","author":"F Tinelli","year":"2020","unstructured":"Tinelli F, Nava S, Arioli F, Bedini G, Scelzo E, Lisini D, Farag\u00f2 G, Gioppo A, Ciceri EF, Acerbi F et al (2020) Vascular remodeling in Moyamoya Angiopathy: from peripheral blood mononuclear cells to endothelial cells. Int J Mol Sci 21:5763","journal-title":"Int J Mol Sci"},{"key":"2448_CR16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.wneu.2017.01.083","volume":"101","author":"JT Hu","year":"2017","unstructured":"Hu JT, Luo J, Chen QX (2017) The susceptibility pathogenesis of Moyamoya Disease. World Neurosurg 101:731\u2013741","journal-title":"World Neurosurg"},{"issue":"3","key":"2448_CR17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3892\/etm.2021.10456","volume":"22","author":"C Wang","year":"2021","unstructured":"Wang C, Sun C, Zhao Y, Song H, Li Z, Jin F, Cui C (2021) RNF213 gene knockdown upregulates transforming growth factor \u03b21 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease[J]. Experimental Therapeutic Med 22(3):1024","journal-title":"Experimental Therapeutic Med"},{"key":"2448_CR18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","volume":"525","author":"M Takeda","year":"2020","unstructured":"Takeda M, Tezuka T, Kim M, Choi J, Oichi Y, Kobayashi H, Harada KH, Mizushima T, Taketani S, Koizumi A et al (2020) Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA\u2009+\u2009domain-dependent manner. Biochem Biophys Res Commun 525:668\u2013674","journal-title":"Biochem Biophys Res Commun"},{"key":"2448_CR19","doi-asserted-by":"crossref","first-page":"687088","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S (2021) RNF213 and GUCY1A3 in Moyamoya Disease: key regulators of metabolism, inflammation, and Vascular Stability. Front Neurol 12:687088","journal-title":"Front Neurol"},{"key":"2448_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ncb3376","volume":"18","author":"RS Banh","year":"2016","unstructured":"Banh RS, Iorio C, Marcotte R, Xu Y, Cojocari D, Rahman AA, Pawling J, Zhang W, Sinha A, Rose CM et al (2016) PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia. Nat Cell Biol 18:803\u2013813","journal-title":"Nat Cell Biol"},{"issue":"10","key":"2448_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","volume":"59","author":"T Mikami","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K et al (2019) Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease[J]. Neurol Med Chir (Tokyo) 59(10):361\u2013370","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"8","key":"2448_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/cells8080784","volume":"8","author":"X FU","year":"2019","unstructured":"FU X, LIU G, HALIM A et al (2019) Mesenchymal stem cell migra tion and tissue repair[J]. Cells 8(8):784","journal-title":"Cells"},{"key":"2448_CR23","first-page":"3095","volume":"19","author":"Y Hu","year":"2019","unstructured":"Hu Y, Li X, Huang G, Wang J, Lu W (2019) Fasudil may induce the differentiation of bone marrow mesenchymal stem cells into neuron like cells via the Wnt\/\u03b2 catenin pathway. Mol Med Rep 19:3095\u20133104","journal-title":"Mol Med Rep"},{"key":"2448_CR24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-170994","volume":"64","author":"S Kawanishi","year":"2018","unstructured":"Kawanishi S, Takata K, Itezono S, Nagayama H, Konoya S, Chisaki Y, Toda Y, Nakata S, Yano Y, Kitamura Y et al (2018) Bone marrow derived Microglia like cells ameliorate brain amyloid Pathology and Cognitive Impairment in a mouse model of Alzheimer\u2019s Disease. J Alzheimers Dis 64:563\u2013585","journal-title":"J Alzheimers Dis"},{"key":"2448_CR25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678\u2013685","journal-title":"Circ Res"},{"key":"2448_CR26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/stem.2808","volume":"36","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Zhang L, Qu Y, Xiao G, Li S, Bao S, Lu QR, Mu D (2018) Mesenchymal stem cells protect against hypoxia-schemia brain damage by enhancing Autophagy through Brain Derived Neurotrophic Factor\/Mammalin Target of Rapamycin Signaling Pathway. Stem Cells 36:1109\u20131121","journal-title":"Stem Cells"},{"key":"2448_CR27","unstructured":"Jianbo Z, Zhenjun L, Wenchao L et al Effects of bone marrow mesenchymal stem cells transplantation on the recovery of neurological functions and the expression of Nogo-A, NgR, Rhoa, and ROCK in rats with experimentally-induced convalescent cerebral ischemia.[J]. Annals of translational medicine, 2020"},{"issue":"5","key":"2448_CR28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/stemcells.2006-0561","volume":"25","author":"JS Bae","year":"2007","unstructured":"Bae JS, Han HS, Youn DH, Carter JE, Modo M, Schuchman EH, Jin HK (2007) Bone marrow derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 25(5):1307\u20131316","journal-title":"Stem Cells"},{"issue":"9","key":"2448_CR29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4103\/1673-5374.165523","volume":"10","author":"YR Zhang","year":"2015","unstructured":"Zhang YR, Ka K, Zhang GC, Zhang H, Shang Y, Zhao GQ, Huang WH (2015) Repair of peripheral nerve defects with chemically extracted acellular nerve allografts loaded with neurotrophic factors-transfected bone marrow mesenchymal stem cells. Neural Regen Res 10(9):1498\u20131506","journal-title":"Neural Regen Res"},{"issue":"2","key":"2448_CR30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","volume":"217","author":"J Rossignol","year":"2011","unstructured":"Rossignol J, Boyer C, L\u00e9v\u00e8que X et al (2011) Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes[J]. Behav Brain Res 217(2):369\u2013378","journal-title":"Behav Brain Res"},{"issue":"6","key":"2448_CR31","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biomaterials.2010.10.041","volume":"32","author":"GJ Delcroix","year":"2011","unstructured":"Delcroix GJ, Garbayo E, Sindji L et al (2011) The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats[J]. Biomaterials 32(6):1560\u20131573","journal-title":"Biomaterials"},{"key":"2448_CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2021","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S, Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health,Labor Welfare, Japan, the Guideline Committee 2021 of the Japan Stroke Society (2021) 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo) 62:165\u2013170","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2448_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahasi J, Katahoka H, Ogasawara K, Iwama T, Tominaga T, Miyamoto S (2022) Diagnostic criteria for moyamoya disease-2021 revised version. Neurol Med Chir (Tokyo) 62:307\u2013312","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2448_CR34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00415-021-10684-6","volume":"269","author":"S Pilgram-Pastor","year":"2022","unstructured":"Pilgram-Pastor S, Chapot R, Kraemer M (2022) The angiographic presentation of European moyamoya angiopathy[J]. Neurol 269:997\u20131006","journal-title":"Neurol"},{"key":"2448_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","volume":"39","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42\u201347","journal-title":"Stroke"},{"key":"2448_CR36","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","volume":"70","author":"Y Mineharu","year":"2008","unstructured":"Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Koizumi A et al (2008) Autosomal dominant moyamoya disease maps to chromosome 17q25.3[J]. Neurology 70:2357\u20132363","journal-title":"Neurology"},{"issue":"1\u20132","key":"2448_CR37","first-page":"161","volume":"353","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Chen YF, Fan PC et al (2015) Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan [J]. J Neurol Sci 353(1\u20132):161\u2013165","journal-title":"J Neurol Sci"},{"issue":"7","key":"2448_CR38","doi-asserted-by":"crossref","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"D Wanyang Liu","year":"2011","unstructured":"Wanyang Liu D, Morito S, Takashima Y, Mineharu H, Kobayashi et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6(7):e22542","journal-title":"PLoS ONE"},{"issue":"10","key":"2448_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s10038-023-01167-9","volume":"68","author":"JP Jeon","year":"2023","unstructured":"Jeon JP (2023) Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. J Hum Genet 68(10):713\u2013720","journal-title":"J Hum Genet"},{"key":"2448_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/STROKEAHA.117.017430","volume":"49","author":"L Duan","year":"2018","unstructured":"Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q et al (2018) Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke 49:11\u201318","journal-title":"Stroke"},{"key":"2448_CR41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","volume":"100","author":"JC Mejia-Munne","year":"2017","unstructured":"Mejia-Munne JC, Ellis JA, Feldstein NA et al (2017) Moyamoya and Inflammation[J]. World Neurosurg 100:575\u2013578","journal-title":"World Neurosurg"},{"key":"2448_CR42","doi-asserted-by":"crossref","unstructured":"Naderi M, Younesi MR, Dorgalaleh A et al (2015) Association between expression of MMP-2 and MMP-9 genes and patho-genesis of intracranial hemorrhage in severe coagulation factor XIII Deficiency[J]. 20(8):487\u2013492 Hematology (Amsterdam, Nether-lands)","DOI":"10.1179\/1607845414Y.0000000226"},{"issue":"11","key":"2448_CR43","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1177\/0271678X18768443","volume":"38","author":"KG Blecharz-Lang","year":"2018","unstructured":"Blecharz-Lang KG, Prinz V, Burek M et al (2018) Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease [J]. J Cereb Blood Flow Metab 38(11):1940\u20131953","journal-title":"J Cereb Blood Flow Metab"},{"key":"2448_CR44","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1038\/srep13191","volume":"5","author":"K Ohkubo","year":"2015","unstructured":"Ohkubo K, Sakai Y, Inoue H et al (2015) Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells[J]. Sci Rep 5:13191","journal-title":"Sci Rep"},{"key":"2448_CR45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A et al (2009) Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72:476\u2013480","journal-title":"Surg Neurol"},{"key":"2448_CR46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.0000046451.38849.90","volume":"107","author":"J Montaner","year":"2003","unstructured":"Montaner J, Molina CA, Monasterio J et al (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagiccomplications after thrombolysis in human stroke. Circulation 107:598\u2013603","journal-title":"Circulation"},{"key":"2448_CR47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH et al (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81:673\u2013678","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2448_CR48","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/01.STR.27.12.2160","volume":"27","author":"T Yoshimoto","year":"1996","unstructured":"Yoshimoto T, Houkin K, Takahashi A et al (1996) Angiogenic factors in moyamoya disease. Stroke 27:2160\u20132165","journal-title":"Stroke"},{"issue":"12","key":"2448_CR49","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.CCM.0000185499.28006.4C","volume":"33","author":"M Perl","year":"2005","unstructured":"Perl M, Chung CS, Ayala A (2005) Apoptosis[J]. Crit Care Med 33(12):526\u2013529","journal-title":"Crit Care Med"},{"issue":"4","key":"2448_CR50","first-page":"2933","volume":"18","author":"DY OuyangL","year":"2019","unstructured":"OuyangL DY (2019) MMP-sensitive PEG hydrogel modified with RGD promotes bFGF,VEGF and EPC-mediated angiogenesis[J]. Exp Ther Med 18(4):2933\u20132941","journal-title":"Exp Ther Med"},{"issue":"1","key":"2448_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12918-018-0668-5","volume":"12","author":"M Song","year":"2018","unstructured":"Song M, Finley SD (2018) Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors[J]. BMC Syst Biol 12(1):145","journal-title":"BMC Syst Biol"},{"key":"2448_CR52","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nn1331","volume":"7","author":"G Liu","year":"2004","unstructured":"Liu G, Beggs H, J\u00fcrgensen C, Park HT, Tang H, Gorski J, Jones KR, Reichardt LF, Wu J, Rao Y (2004) Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction. Nat Neurosci 7:1222\u20131232","journal-title":"Nat Neurosci"},{"key":"2448_CR53","doi-asserted-by":"crossref","first-page":"101678","DOI":"10.1016\/j.tice.2021.101678","volume":"74","author":"B Liu","year":"2022","unstructured":"Liu B, Zheng W, Dai L, Fu S, Shi E (2022) Bone marrow mesenchymal stem cell derived exosomal Mi R-455-5p protects against spinal cord ischemia reperfusion injury. Tissue Cell 74:101678","journal-title":"Tissue Cell"},{"issue":"1","key":"2448_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/acschemneuro.1c00599","volume":"13","author":"Q Lei","year":"2022","unstructured":"Lei Q, Deng M, Liu J, He J, Lan Z, Hu Z, Xiao H (2022) SRC3 promotes the Protective effects of Bone Marrow Mesenchymal Stem Cell transplantation on cerebral ischemia in a mouse model. ACS Chem Neurosci 13(1):112\u2013119","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2448_CR55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12015-021-10178-y","volume":"18","author":"XY Lan","year":"2022","unstructured":"Lan XY, Sun ZW, Xu GL, Chu CY, Qin HM, Li S, Geng X, Gao P, Boltze J, Li S (2022) Bone marrow mesenchymal stem cells exert protective effects after ischemic stroke through upregulation of glutathione. Stem Cell Rev Rep 18(2):585\u2013594","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"2448_CR56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.sjbs.2019.12.016","volume":"27","author":"Z Liming","year":"2020","unstructured":"Liming Z, Weiliang S, Hao L et al (2020) Therapeutic effect of autologous bone marrow stem cell mobilization combined with anti-infective therapy on moyamoya disease.[J]. Saudi J Biol Sci 27(2):676\u2013681","journal-title":"Saudi J Biol Sci"},{"key":"2448_CR57","doi-asserted-by":"crossref","unstructured":"Liming ZTL, Bingqian X et al Influence of autologous bone marrow stem cell therapy on the levels of inflammatory factors and Conexin43 of patients with Moyamoya Disease.[J]. Comput Intell Neurosci 2022:20227620287","DOI":"10.1155\/2022\/7620287"},{"issue":"4","key":"2448_CR58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14712591003610606","volume":"10","author":"WM Jackson","year":"2010","unstructured":"Jackson WM, Nesti LJ, Tuan RS (2010) Potential therapeutic applications of muscle- derived mesenchymal stem and progenitor cells[J]. Expert Opin Biol Ther 10(4):505\u2013517","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"2448_CR59","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3324\/haematol.2009.013151","volume":"95","author":"X Wang","year":"2010","unstructured":"Wang X, Hisha H, Mizokami T et al (2010) Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule[J]. Haematologica 95(6):884\u2013891","journal-title":"Haematologica"},{"issue":"4","key":"2448_CR60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy 8(4):315\u2013317","journal-title":"Cytotherapy"},{"key":"2448_CR61","first-page":"49","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M (2015) Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49\u201368","journal-title":"Appl Clin Genet"},{"key":"2448_CR62","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/jcm10132815","volume":"10","author":"Y Hirano","year":"2021","unstructured":"Hirano Y, Miyawaki S, Imai H et al (2021) Differences in clinical features among different onset patterns in moyamoya disease. J Clin Med 10:2815","journal-title":"J Clin Med"},{"key":"2448_CR63","first-page":"555","volume":"12","author":"T Hiraide","year":"2022","unstructured":"Hiraide T et al (2022) RNF213-associated vascular disease: a concept unifying various vasculopathies. Life (Basel) 12:555","journal-title":"Life (Basel)"},{"issue":"9","key":"2448_CR64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/01616412.2019.1615726","volume":"41","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, Fujimura M, Sakata H et al (2019) Genetic analysis of ring finger protein 213 (RNF213) c.14576G\u2009>\u2009A polymorphism in patients with vertebral artery dissection: a comparative study with moyamoya disease[J]. Neurol Res 41(9):811\u2013816","journal-title":"Neurol Res"},{"issue":"11","key":"2448_CR65","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"X Fei Ye","year":"2023","unstructured":"Fei Ye X, Niu F, Liang Y, Dai J, Liang J, Li et al (2023) RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain 146(11):4674\u20134689","journal-title":"Brain"},{"key":"2448_CR66","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/0271678X20914996","volume":"41","author":"J Lin","year":"2021","unstructured":"Lin J, Liang J, Wen J et al (2021) Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish. J Cereb Blood Flow Metab 41:1251\u20131263","journal-title":"J Cereb Blood Flow Metab"},{"key":"2448_CR67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cells12010078","volume":"12","author":"V Roy","year":"2022","unstructured":"Roy V, Brodeur A, Touzel Deschenes L, Dupre N, Gros-Louis F (2022) RNF213 loss-of-function promotes angiogenesis of cerebral microvascular endothelial cells in a cellular state dependent manner. Cells 12:78","journal-title":"Cells"},{"issue":"3\u20134","key":"2448_CR68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000499699","volume":"47","author":"S Nomura","year":"2019","unstructured":"Nomura S, Yamaguchi K, Akagawa H et al (2019) Genotype-phenotype correlation in long-term cohort of Japanese patients with Moyamoya Disease[J]. Cerebrovasc Dis 47(3\u20134):105\u2013111","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"2448_CR69","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z et al (2014) RNF213 rare variants in an ethnically diverse population with Moyamoya disease [J]. Stroke 45(11):3200\u20133207","journal-title":"Stroke"},{"issue":"11","key":"2448_CR70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H et al (2012) Homozygous c.14576G\u2009>\u2009A variant of RNF213 predicts early-onset and severe form of moyamoya disease[J]. Neurology 78(11):803\u2013810","journal-title":"Neurology"},{"key":"2448_CR71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11011-020-00616-0","volume":"36","author":"W Han","year":"2021","unstructured":"Han W, Qiao Y, Zhang H, Geng C, Zhu X, Liao D, Guo Y, Yang M, Chen D, Jiang P (2021) Circulating sortilin levels are associated with inflammation in patients with moyamoya disease. Metab Brain Dis 36:103\u2013109","journal-title":"Metab Brain Dis"},{"issue":"3","key":"2448_CR72","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/bc.bc_38_19","volume":"5","author":"S Corey","year":"2019","unstructured":"Corey S, Luo Y (2019) Circular RNAs and neutrophils: key factors in tackling asymptomatic moyamoya disease. Brain Circ 5(3):150\u2013155","journal-title":"Brain Circ"},{"issue":"3","key":"2448_CR73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.201712120","volume":"218","author":"M Sugihara","year":"2019","unstructured":"Sugihara M, Morito D, Ainuki S et al (2019) The AAA\u2009+\u2009ATPase\/ ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets[J]. J Cell Biol 218(3):949\u2013960","journal-title":"J Cell Biol"},{"issue":"14","key":"2448_CR74","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.111.040352","volume":"125","author":"JC Kovacic","year":"2012","unstructured":"Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V (2012) Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease[J]. Circulation 125(14):1795\u20131808","journal-title":"Circulation"},{"issue":"2","key":"2448_CR75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y et al (2014) Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene[J]. Stroke 16(2):65\u201372","journal-title":"Stroke"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-02448-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:41:58Z","timestamp":1741084918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-02448-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-02448-3","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project approved by the Ethics Committee of the Affiliated Hospital of Jining Medical University (approval number for human: 2020-10-B006; approval number for animal: 2020C053). All procedures were conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent and consented to publish the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent to publish"}},{"value":"The authors have no conficts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"246"}}